Grifols Biologicals Inc. (GBI) is a biopharmaceutical company which manufactures plasma derivatives for the treatment of disease states such as Hemophilia and Primary Immune Deficiency.   In the process of manufacturing these life-saving therapies, GBI avails themselves to the latest technology for protein purification.  In addition, our FDA-licensed installations and processes comply with Good Manufacturing Practices.

GBI currently employs 450 people in many disciplines including manufacturing, quality control, quality assurance, maintenance and other administrative functions.  We are also in the middle of modernizing many of our facilities as well as expanding our overall production capacity.  These exciting projects will lead to a need for additional personnel in all facets of our business.

Come be part of our manufacturing team as we focus on producing key plasma derived products of proven efficacy, quality and safety.